X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/03/28/2853915/0/en/Ceapro-Receives-Final-Court-Approval-for-Merger-with-Aeterna-Zentaris.html
https://www.globenewswire.com/news-release/2024/03/27/2853131/0/en/Aeterna-Zentaris-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Announces-Completion-of-Enrollment-in-Ongoing-Pivotal-DETECT-Trial-for-the-Diagnosis-of-Childhood-O.html
https://www.globenewswire.com//news-release/2024/03/12/2844946/0/en/Aeterna-Zentaris-and-Ceapro-Merger-Approved-by-Securityholders-at-Special-Meetings.html
https://www.globenewswire.com//news-release/2024/02/26/2835030/0/en/Leading-Independent-Proxy-Advisory-Firm-ISS-Recommends-Aeterna-Zentaris-and-Ceapro-Securityholders-Vote-FOR-the-Arrangement-Agreement-to-Approve-the-Merger-of-Equals-to-Create-a-Di.html
https://www.globenewswire.com//news-release/2024/02/15/2830459/0/en/Ceapro-Inc-Announces-the-Mailing-of-Meeting-Materials-in-Connection-With-the-Special-Meeting-of-Securityholders-to-Approve-Merger-With-Aeterna-Zentaris.html
https://www.globenewswire.com//news-release/2023/12/14/2796184/0/en/Aeterna-Zentaris-and-Ceapro-Announce-Merger-of-Equals-to-Create-a-Diversified-Biopharmaceutical-Company.html
https://www.globenewswire.com//news-release/2023/11/09/2777310/0/en/Aeterna-Zentaris-Reports-Third-Quarter-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2023/10/11/2758316/0/en/Aeterna-Zentaris-to-Participate-at-the-Virtual-Investor-Ask-the-CEO-Conference.html
https://www.globenewswire.com//news-release/2023/09/05/2737275/0/en/Aeterna-Zentaris-to-Present-at-the-H-C-Wainwright-25th-Annual-Global-Investment-Conference.html
https://www.globenewswire.com/news-release/2023/08/09/2721605/0/en/Aeterna-Zentaris-Reports-Second-Quarter-2023-Financial-Results.html
Market Place
Share 
